丹参及其制剂治疗妊娠病的研究进展
Research Advances in Salvia miltiorrhiza and Its Preparations for Gestational Diseases
DOI: 10.12677/tcm.2025.1411709, PDF,   
作者: 魏士焱：黑龙江中医药大学研究生院，黑龙江 哈尔滨；杨新鸣*：黑龙江中医药大学附属第一医院妇科一科，黑龙江 哈尔滨
关键词: 丹参；复方丹参注射液；妊娠病；Salvia miltiorrhiza； Compound Danshen Injection； Gestational Diseases
摘要: 丹参通过发挥其活血祛瘀、通经止痛的功效，以及改善胎盘微循环、调节凝血–纤溶平衡、抑制氧化应激等现代药理作用，在复发性流产、妊娠期高血压疾病、妊娠期肝内胆汁淤积症、羊水过少、胎儿生长受限及异位妊娠等多种妊娠疾病的治疗中疗效显著。本综述围绕上述疾病，分别从基础与临床角度对研究进展予以综述，以期为未来的研究与应用提供借鉴。
Abstract: Salvia miltiorrhiza demonstrates significant therapeutic effects in the treatment of various gestational diseases, including recurrent miscarriage, hypertensive disorders of pregnancy, intrahepatic cholestasis of pregnancy, oligohydramnios, fetal growth restriction, and ectopic pregnancy. These benefits are attributed to its traditional actions of promoting blood circulation and removing blood stasis, dredging meridians and relieving pain, as well as its modern pharmacological effects such as improving placental microcirculation, regulating coagulation-fibrinolysis balance, and inhibiting oxidative stress. This review summarizes recent advances in both basic and clinical research on the aforementioned diseases, with the aim of providing references for future studies and applications.
文章引用：魏士焱, 杨新鸣. 丹参及其制剂治疗妊娠病的研究进展[J]. 中医学, 2025, 14(11): 4915-4923. https://doi.org/10.12677/tcm.2025.1411709

参考文献

[1] Ewing, M.M., de Vries, M.R., Nordzell, M., Pettersson, K., de Boer, H.C., van Zonneveld, A.J., et al. (2011) Annexin A5 Therapy Attenuates Vascular Inflammation and Remodeling and Improves Endothelial Function in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 95-101. [Google Scholar] [CrossRef] [PubMed]
[2] Larkin, S., Emeis, J., Allison, A. and Kuypers, F. (2007) Interaction of an Annexin V Homodimer (Diannexin) with Phosphatidylserine on Cell Surfaces and Consequent Antithrombotic Activity. Thrombosis and Haemostasis, 97, 478-486. [Google Scholar] [CrossRef] [PubMed]
[3] 方小桂, 时雪飞, 童芳芳. 膜联蛋白A5水平检测在妊娠中期胎儿宫内生长受限诊断中的应用研究[J]. 中国当代医药, 2014, 21(33): 31-32+35.
[4] 段志颖, 童星丽, 黄紫微, 等. 丹参酮ⅡA对反复流产小鼠模型蜕膜组织、胎盘膜联蛋白A5表达的影响[J]. 中成药, 2021, 43(11): 3182-3186.
[5] Ruffatti, A., Favaro, M., Tonello, M., De Silvestro, G., Pengo, V., Fais, G., et al. (2005) Efficacy and Safety of Nadroparin in the Treatment of Pregnant Women with Antiphospholipid Syndrome: A Prospective Cohort Study. Lupus, 14, 120-128. [Google Scholar] [CrossRef] [PubMed]
[6] Tanaka, Y., Ishii, H., Hiraoka, M., Miyasaka, N., Kuroiwa, T., Hajjar, K.A., et al. (2007) Efficacy of Recombinant Annexin 2 for Fibrinolytic Therapy in a Rat Embolic Stroke Model: A Magnetic Resonance Imaging Study. Brain Research, 1165, 135-143. [Google Scholar] [CrossRef] [PubMed]
[7] Boyama, B.A., Cepni, I., Imamoglu, M., Oncul, M., Tuten, A., Yuksel, M.A., et al. (2016) Homocysteine in Embryo Culture Media as a Predictor of Pregnancy Outcome in Assisted Reproductive Technology. Gynecological Endocrinology, 32, 193-195. [Google Scholar] [CrossRef] [PubMed]
[8] 童星丽, 郭银华, 聂晓伟, 等. 丹参酮ⅡA对复发性流产小鼠模型蜕膜组织膜联蛋白A2 mRNA及蛋白表达的影响[J]. 中华中医药杂志, 2022, 37(1): 483-486.
[9] Chen, Y., Wu, Q., Wei, J., Hu, J. and Zheng, S. (2021) Effects of Aspirin, Vitamin D3, and Progesterone on Pregnancy Outcomes in an Autoimmune Recurrent Spontaneous Abortion Model. Brazilian Journal of Medical and Biological Research, 54, e9570. [Google Scholar] [CrossRef] [PubMed]
[10] 黄露, 黄海珍. 基于NOD1/RIP2/NF-κB信号通路探讨丹参酮ⅡA对复发性流产小鼠子宫母胎界面免疫状态的影响[J]. 贵州医科大学学报, 2025, 50(3): 405-410+416.
[11] Li, F., Li, X.L., Chen, S.J., Tan, C., Mei, S.P., Jia, H.G., et al. (2021) Excretory/Secretory Proteins of Adult Toxocara Canis Induce Changes in the Expression of Proteins Involved in the NOD1-RIP2-NF-κB Pathway and Modulate Cytokine Production in Mouse Macrophages. Experimental Parasitology, 229, Article 108152. [Google Scholar] [CrossRef] [PubMed]
[12] 周立. 复方丹参注射液联合寿胎丸治疗复发性流产临床观察[J]. 中医药临床杂志, 2016, 28(1): 60-62.
[13] 刘银姣, 刘蔚霞, 马素娟, 等. 丹参注射液治疗复发性流产早期临床观察[J]. 光明中医, 2021, 36(6): 851-854.
[14] 易思捷, 金夏, 魏婧媛. 丹参酮ⅡA联合低分子肝素和阿司匹林治疗早孕子宫动脉血流阻力偏高复发性流产的临床效果[J]. 中国妇幼保健, 2024, 39(5): 846-850.
[15] 钱秋然, 张圆圆, 王杰平, 等. 丹参注射液联合低分子肝素治疗对高凝状态复发性流产患者凝血功能及妊娠结局的影响[J]. 临床医学工程, 2023, 30(5): 617-618.
[16] 王丽娜, 卫爱武, 刘蔚霞. 复方丹参注射液治疗反复性流产30例[J]. 四川中医, 2006(5): 79-80.
[17] Phipps, E.A., Thadhani, R., Benzing, T. and Karumanchi, S.A. (2019) Pre-Eclampsia: Pathogenesis, Novel Diagnostics and Therapies. Nature Reviews Nephrology, 15, 275-289. [Google Scholar] [CrossRef] [PubMed]
[18] Ramos, J.G.L., Sass, N. and Costa, S.H.M. (2017) Preeclampsia. Revista Brasileira de Ginecologia e Obstetrícia: Revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 39, 496-512. [Google Scholar] [CrossRef] [PubMed]
[19] El-Sayed, A.A.F. (2017) Preeclampsia: A Review of the Pathogenesis and Possible Management Strategies Based on Its Pathophysiological Derangements. 56, 593-598. [Google Scholar] [CrossRef] [PubMed]
[20] Li, F., Han, N., Wang, Y. and Xu, Q. (2018) Gadd45a Knockdown Alleviates Oxidative Stress through Suppressing the P38 MAPK Signaling Pathway in the Pathogenesis of Preeclampsia. Placenta, 65, 20-28. [Google Scholar] [CrossRef] [PubMed]
[21] Yang, Y. and Shang, H. (2021) Silencing Lncrna-Dgcr5 Increased Trophoblast Cell Migration, Invasion and Tube Formation, and Inhibited Cell Apoptosis via Targeting miR-454-3p/GADD45A Axis. Molecular and Cellular Biochemistry, 476, 3407-3421. [Google Scholar] [CrossRef] [PubMed]
[22] Yang, Y., Shang, H., Sun, J., Shi, X. and Zhou, B. (2023) Tanshinol Inhibits Trophoblast Cell Migration and Invasion by Regulating Gadd45a in Preeclampsia. Journal of Obstetrics and Gynaecology, 43, Article 2274527. [Google Scholar] [CrossRef] [PubMed]
[23] 刘颖. 复方丹参注射液联合硫酸镁治疗妊高症的临床效果分析[J]. 心血管外科杂志(电子版), 2018, 7(4): 641-642.
[24] 蔡红莲, 刘霞. 硫酸镁联合复方丹参注射液用于妊高症治疗效果及不良反应观察[J]. 医学理论与实践, 2019, 32(13): 2078-2080.
[25] 李玉梅. 复方丹参注射液与硫酸镁联合用于妊高症治疗中的临床疗效[J]. 临床医药文献电子杂志, 2018, 5(57): 62+64.
[26] 邱丹花. 复方丹参注射液对妊高症患者GHS-RmRNA及Ghrelin表达的影响[J]. 中国医药科学, 2016, 6(24): 38-40.
[27] Zhou, Y., Wang, J., Wang, L., Tang, J. and Zhang, C. (2022) Effect of Compound Danshen Injection Combined with Magnesium Sulfate on Oxidative Stress, TNF-α, NO, and Therapeutic Efficacy in Severe Preeclampsia. Computational Intelligence and Neuroscience, 2022, Article ID: 9789066. [Google Scholar] [CrossRef] [PubMed]
[28] 李姣, 邱冉冉. 复方丹参注射液对早发型子痫前期IGF-1、PLGF水平及妊娠危重结局的影响研究[J]. 中华中医药学刊, 2020, 38(11): 251-254.
[29] 赵胜伟. 复方丹参注射液对妊高症患者血压、血浆内皮素及妊娠结局的影响探讨[J]. 中国现代药物应用, 2019, 13(23): 18-20.
[30] 袁静. 复方丹参注射液治疗妊高症对患者血清内皮素及一氧化氮水平的影响分析[J]. 四川解剖学杂志, 2020, 28(3): 90-91.
[31] Ji, R., Gan, Q., Shu, X., Xu, R., Huang, X. and Shen, T. (2024) The Efficacy of Salvia-Ligustrazine and Ligustrazine in Treating Gestational Hypertension: A Systematic Review and Meta-analysis. Biomolecules and Biomedicine, 24, 1517-1534. [Google Scholar] [CrossRef] [PubMed]
[32] Hofmann, A.F. (2004) Detoxification of Lithocholic Acid, a Toxic Bile Acid: Relevance to Drug Hepatotoxicity. Drug Metabolism Reviews, 36, 703-722. [Google Scholar] [CrossRef] [PubMed]
[33] Hrycay, E., Forrest, D., Liu, L., Wang, R., Tai, J., Deo, A., et al. (2014) Hepatic Bile Acid Metabolism and Expression of Cytochrome P450 and Related Enzymes Are Altered in Bsep −/− Mice. Molecular and Cellular Biochemistry, 389, 119-132. [Google Scholar] [CrossRef] [PubMed]
[34] Li, Y., Wang, Q., Jin, J., Tan, B., Ren, J., Song, G., et al. (2023) 15,16-Dihydrotanshinone I in Danshen Ethanol Extract Aggravated Cholestasis by Inhibiting Cyp3a11 Mediated Bile Acids Hydroxylation. Toxicology Letters, 377, 62-70. [Google Scholar] [CrossRef] [PubMed]
[35] 潘峥, 覃冠德, 罗文勇. 思美泰联合丹参治疗妊娠期肝内胆汁淤积症的疗效观察[J]. 中国医药指南, 2013, 11(16): 189-190.
[36] 潘峥, 覃冠德, 罗文勇. 熊去氧胆酸联合丹参治疗妊娠期肝内胆汁淤积症临床分析[J]. 山西医药杂志(下半月刊), 2013, 42(4): 408-409.
[37] 于亚莉, 冯辉. 复方丹参注射液联合多烯磷脂酰胆碱治疗对妊娠期肝内胆汁淤积症患者血清VEGF、IFN-γ水平及新生儿结局的影响[J]. 中国妇幼保健, 2018, 33(11): 2438-2441.
[38] 周虹. 丹参注射液对妊娠期肝内胆汁淤积症患者脐动脉血流的影响[J]. 中国中医药信息杂志, 2004(3): 195-196.
[39] 杜逸亭, 李丽, 王译, 等. 复方丹参治疗妊娠期肝内胆汁淤积症所致新生儿脑损伤的临床观察[J]. 四川医学, 2014, 35(11): 1392-1394.
[40] Shen, Q., Wang, J., Zhou, Q., Shen, Z., Luo, H., Tao, X. and Zhu, X. (2017) Linking Expression of Aquaporin 3 to Activation of JNK Pathway. Frontiers in Bioscience, 22, 258-267. [Google Scholar] [CrossRef] [PubMed]
[41] Hua, Y., Ding, S., Cheng, H., Luo, H. and Zhu, X. (2017) Tanshinone IIA Increases Aquaporins Expression in Human Amniotic Epithelial WISH Cells by Stimulating GSK-3β Phosphorylation. Clinica Chimica Acta, 473, 204-212. [Google Scholar] [CrossRef] [PubMed]
[42] 陈再玲, 於丽华, 李爱金, 等. 复方丹参注射液对羊水过少孕妇MMPs、TIMPs、炎症因子及宫腔环境的影响[J]. 中成药, 2017, 39(12): 2635-2638.
[43] 许明跃. 复方丹参注射液联合低分子肝素在羊水过少孕妇中的应用效果[J]. 医学理论与实践, 2024, 37(23): 4043-4045.
[44] 马达, 董雪娜. 复方丹参注射液联合右旋糖酐40治疗妊娠晚期特发性临界羊水过少的效果[J]. 临床合理用药, 2023, 16(15): 125-127.
[45] 王健. 黄芪代茶饮联合复方丹参注射液对妊娠晚期羊水过少者的疗效[J]. 内蒙古中医药, 2021, 40(9): 46-47.
[46] 胡妮. 硫酸镁联合丹参注射液对羊水过少的疗效[J]. 中国继续医学教育, 2021, 13(4): 142-145.
[47] 刘丹, 练湘红, 张伶俐, 等. 丹参注射液超说明书治疗胎儿生长受限的系统评价[J]. 中国医院用药评价与分析, 2016, 16(10): 1370-1373.
[48] 兰秋丽, 傅晓冬. 丹参联合硫酸镁治疗胎儿生长受限的Meta分析[J]. 包头医学院学报, 2021, 37(11): 89-92+100.
[49] 滕玲玲, 李燕敏, 董高霞. 硫酸镁注射液联合丹参注射液对胎儿生长受限孕妇血清相关生长因子及胎儿生长发育的影响[J]. 河北中医, 2021, 43(7): 1149-1152.
[50] 王平娟, 李慧娟, 王晓静. 丹参注射液联合硫酸镁治疗胎儿生长受限的临床研究[J]. 药物评价研究, 2020, 43(11): 2263-2267.
[51] 任国平, 王保莲, 毕春燕, 等. 丹参注射液联合肝素治疗胎儿生长受限的临床疗效及对孕妇血流变的影响[J]. 世界中医药, 2017, 12(5): 1032-1036.
[52] 朱薏, 路妍妍, 田耕. 丹参注射液与低分子肝素治疗胎儿生长受限的临床疗效比较[J]. 现代医院, 2016, 16(4): 483-485.
[53] 梁敏. 丹参注射液与低分子肝素治疗胎儿生长受限的临床疗效对比[J]. 中外女性健康研究, 2018(3): 127+146.
[54] 张红花. 丹参、黄芪、麦冬治疗胎儿生长受限疗效探讨[J]. 实用中西医结合临床, 2006(4): 9-10.
[55] 张雪清, 骆雪, 刘厚材, 等. 基于数据挖掘探析近15年中药治疗异位妊娠的用药规律[J]. 中医临床研究, 2024, 16(22): 40-46.
[56] 邱嘉菡, 袁烁, 张家旗, 等. 基于网络药理学的宫外孕Ⅰ号方治疗异位妊娠的作用机制研究[J]. 中国医药导报, 2021, 18(22): 4-11+197.
[57] 陈思, 李净, 刘晓荣, 等. 基于网络药理学的宫外孕Ⅱ号方治疗异位妊娠作用机制[J]. 中成药, 2019, 41(7): 1538-1547.
[58] 陈友葵, 徐秀文, 段润英. 复方丹参注射液治疗宫外孕血肿包块103例[J]. 山西医学院学报, 1993(2): 223-224.
[59] 王向红, 卢书芳. 复方丹参注射液辅助甲氨蝶呤治疗宫外孕的临床疗效分析[J]. 药物评价研究, 2019, 42(4): 701-704.